RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Taisho Pharmaceutical Holdings
T

Taisho Pharmaceutical Holdings portfolio

Taisho Pharmaceutical Holdings has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Biolinq's $100M Series B+ round in April 2025, alongside RiverVest, M Ventures, LifeSci Venture Partners and 5 others. That company is in Health and bio. It has co-invested with RiverVest, M Ventures and Hikma Ventures, most often RiverVest (2 rounds).

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $200M.
Latest deal: Biolinq · Apr 22, 2025.

What Taisho Pharmaceutical Holdings invests in

How Taisho Pharmaceutical Holdings invests

StageDealsCapital in rounds
Series B+ 2 100%$200M
YearDealsCapital in rounds
2021 1 50%$100M
2025 1 50%$100M

Share is of the 2 rounds on Recent Funding that name Taisho Pharmaceutical Holdings. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Taisho Pharmaceutical Holdings portfolio companies

CompanyRound with Taisho Pharmaceutical HoldingsTotal raisedLatest raise
BBiolinq
Health and bio
Series B+ · $100M$214.75MApr 22, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Taisho Pharmaceutical Holdings, which is a subset of its real portfolio. API: /api/v1/investors/taisho-pharmaceutical-holdings (get a free API key). More: the most active VC firms and new venture capital funds.